5 colspan 2 style text align center font size larger Serono colspan 2 style padding 1em 0 text align center Image Serono logo.png style vertical align top text align left category types of companies ... http www.serono.com Serono is a biotechnology company law company headquartered in Geneva , Switzerland . The company was founded as the Serono Pharmacolodgical Institute by Cesare Serono in 1906 in Italy ..., notably Pergonal . Serono was incorporated in 1987 and the holding company, Ares Serono S.A., changed its name to Serono S.A. in May 2000. Serono as a stand alone company develops and markets ... market share of 60 , making it the third largest biotechnology company in the world. Serono ... , dermatology , where Serono has launched biologics in Europe for moderate to severe psoriasis ... also conducts research in oncology and autoimmune diseases . Sale to Merck KGaA 36 of Serono ... entity, which merges Serono with Merck s Ethicals division, is called Merck Serono Merck Serono . Its headquarters is in Geneva, within the new Serono facilities. The US operations are planned ... reviews and phases are complete. Until that time, Serono and Merck KGaA still operate as separate entities. The new, combined entity, Merck Serono is expected to equal the sizes of other large biotechs ... than 8 billion euros Facilities Serono operates in 44 countries, with manufacturing facilities in eight ... development projects at the end of 2005. Serono Headquarters and the Geneva research site moved to a brand new campus Horizon Secheron in the heart of Geneva in 2006. Fertility LifeLines Serono provides ... merck serono sa A Company Profile http www.merck.de Merck KGaA corporate homepage http www.piribo.com publications pharmaceutical companies seronoserono pharmaceutical company intelligence report.html Serono Pharmaceutical Company Intelligence Notes note origin http www.serono.com ir pdf form20F ... Taiwan http www.seronousa.com USA Complete Company Profile http www.serono.com Serono ... more details
the majority of Serono shares from Ernesto Bertarelli and the Bertarelli family. The Merck Serono merger was announced on September 21, 2006. Merck KGaA and Serono operated as distinct entities until at least January 2007. As of January 5, 2007, Merck held the majority shares of Serono. The new company is called Merck Serono International S.A. Merck KGaA is a completely separate company from the US company Merck & Co. . Therefore, in the US & Canada, Merck Serono is known as EMD Serono ... Research In addition to internal research and development activities Merck Serono is also ... Reflist External links http www.serono.com Merck Serono company website Portal Companies Category ... Serono it Merck Serono ja no Merck Serono ... more details
File image originally from http www.serono.com index.jsp, original file path was http www.serono.com img logo.gif. Downloaded 3 Jul 2005. Non free logo History of File Serono logo.gif 2007 04 23T19 19 27Z User Cydebot Cydebot User talk Cydebot Talk Special Contributions Cydebot contribs 161 bytes nowiki Robot Renaming non free template logo per Wikipedia Non free content templates . nowiki 2005 08 14T22 09 04Z User Ceyockey Ceyockey User talk Ceyockey Talk Special Contributions Ceyockey contribs nowiki template logo added nowiki 2005 07 03T01 55 54Z User Ceyockey Ceyockey User talk Ceyockey Talk Special Contributions Ceyockey contribs nowiki File image originally from http www.serono.com index.jsp, original file path was http www.serono.com img logo.gif. Downloaded 3 Jul 2005. Original purpose inclusion in Infobox Company for Serono . I consider this a matter of Fair Use. nowiki 2005 07 03T01 55 54Z User Ceyockey Ceyockey User talk Ceyockey Talk Special Contributions Ceyockey contribs 161x45 1082 bytes ... more details
Serostim recombinant DNA somatropin is Serono s brand name prescription drug form of recombinant DNA synthetic growth hormone , marketed for AIDS cachexia wasting . ref http www.serostim.com ref In December 2007, the U.S. District Court of Massachusetts settled a class action lawsuit that involved Merck Serono and the drug Serostim. The lawsuit claims that Merck Serono encouraged doctors to prescribe Serostim off label for criteria that were not approved by the FDA. Merck Serono denies these claims and any liability. However, Merck Serono has entered into a settlement solely to avoid the further expense, inconvenience, burden, and uncertainty of these lawsuits. The settlement will pay consumers of Serostim who paid the full cash amount or a co payment as part of their medical treatment. References references External links http www.serostimsettlement.com Category Growth hormones Category Hormonal agents systemic hormonal drug stub ... more details
distinguish mIRC Merc disambiguation Merc Merk disambiguation Merk Merck may refer to Merck KGaA , EMD Chemicals in the United States and Canada , a German based chemical and pharmaceutical company. Merck Serono EMD Serono in North America , the pharmaceutical division of Merck KGaA Merck family , a family of pharmacists who eventually founded Merck KGaA Merck & Co. , Inc. Merck Sharp & Dohme outside North America , an American pharmaceutical company created after World War I from assets forfeited by Merck KGaA, though the two are unassociated Merck Manual of Diagnosis and Therapy , a medical textbook published by Merck & Co Merck Index , an encyclopedia of Chemistry, published by Merck & Co Merck Records , an IDM and experimental hip hop record label based in Miami, Florida, USA disambig Category Merck de Merck es Merck fr Merck it Merck hu Merck egy rtelm s t lap ja Merck no Merck nn Merck pl Merck pt Merck ru Merck ... more details
shake it. The actual manufacturers of HGH rDNA such as Merck EMD Serono and Eli Lilly ... if shaken too rigorously. The reason is that HGH is a protein and Serono and Eli Lilly warn against ... Official website http www.emdserono.com United States Serono http www.drcranton.com hrt cautions ... more details
2011 Business Bertarelli was active in Serono, the family business, and from 1992 to 1997 was Executive Director, Public and Professional Affairs, where she established http www.seronosymposia.org Serono Symposia and the Serono Foundation. The company was sold to Merck KGaA at the beginning of 2007. ref http www.merck.de en investors ad hoc announcements acquisition of serono acquisition of serono.html The Merck Group Acquisition of Serono S.A Bot generated title ref The five star Grand H tel ... more details
The Bioindustry Park Silvano Fumero BiPCa is a Science park Science and Technology Park located in Canavese near Turin in the north west of Italy . The park was founded to promote and develop biotechnological research, to host companies operating research and development , and pilot production in the life science sector. Companies such as Serono Merck Serono and Bracco chose the Park as the location for their research and development activities. Services The Park offers a complete set of support services to R&D activities, not only offering research facilities and scientific services, but also flexible and attractive financing solutions, sound project management and results evaluation. The park is the owner of the Laboratory for Advanced Methodologies LIMA which performs exploitation of scientific results in the fields of Chemistry , Molecular Biology , Proteomics and Bioinformatics . LIMA, thanks to its solid co operation with the University of Turin and CNR ISPA Consiglio Nazionale delle Ricerche , is also a permanent training site for graduates and researchers. A University Center in Imaging Technologies CEIP managed by University of Torino is also active and is focused on the use of different technologies MRI , Ultrasound , X ray , etc. in order to evaluate new solutions in the diagnosis and assessment of the efficacy and efficiency of drug s. Start ups In 2005 BiPCa has launched, with the support of Regions of Italy Regione Piemonte , the Discovery initiative to identify and select innovative entrepreneurial ideas in the Biotech field. Eight start ups have already been created from the beginning of the project in partnership with Eporgen venture, a Seed capital company focused on investment in new innovative entrepreneurial projects in the biotech field. Local cluster Bioindustry Park is also acting as system integrator for the development of a Business cluster local cluster , bioPmed http www.biopmed.eu . Since 2009 Bioindustry Park acts as cluster management ... more details
to Merck Serono in 2006. In October 2011 Merck Serono announced that they would give all rights ... Serono http www.merckserono.com corp.merckserono en images 20070608 de tcm112 16874.pdf Vielversprechende ... more details
merck serono and zymogenetics initiate atacicept phase 2 clinical trial in relapsing multiple sclerosis 562995 title Merck Serono and ZymoGenetics Initiate Atacicept Phase 2 Clinical Trial in Relapsing ... to Merck Serono for further development. ref cite web url http www.xconomy.com boston 2008 09 03 ... more details
Infobox organization name Division of Signal Transduction Therapy image image border size default 200 alt alt text see WP ALT caption map optional msize map size, optional, default 200px malt map alt text mcaption optional abbreviation motto formation 1998 extinction date of extinction, optional type GO, NGO, IGO, INGO, etc status ad hoc, treaty, foundation, etc purpose focus as e.g. humanitarian, peacekeeping, etc headquarters location coords Coordinates of location using a coordinates template region served membership language official languages leader title position title for the leader of the org leader name Philip Cohen , Peter Downes, Dario Alessi main organ gral. assembly, board of directors, etc parent organization University of Dundee affiliations AstraZeneca , Boehringer Ingelheim , GlaxoSmithKline , Merck Serono and Pfizer num staff 200 num volunteers budget 2.75 million year website http www.lifesci.dundee.ac.uk dstt remarks The Division of Signal Transduction Therapy or DSTT is an organization managed by the University of Dundee and pharmaceutical companies including AstraZeneca , Boehringer Ingelheim , GlaxoSmithKline , Merck Serono and Pfizer . The purpose of the collaboration is to do general cell signaling research and to encourage development of therapeutic protein kinase inhibitors and phosphatases . It is one of the largest ever collaborations between the commercial pharmaceutical industry and any academic research institute. Organizational resources and management The organization was founded in 1998. In 2003 the organization s existence was renewed with 15 million funding, and in 2008 further renewed with 11 million. It is made up of nearly 200 scientific and support staff in the University of Dundee. The amount of funding and staff make DSTT the largest collaboration between the for profit pharmaceutical industry and a university in the United Kingdom . ref name mainsite cite web url http www.lifesci.dundee.ac.uk dstt title Division of Signal ... more details
EMD may refer to Music E.M.D. , a Swedish band The Explorations in Music and Dance EMD Network , represents diverse higher education institutions of dance and music in Greenland, Finland, Sweden, Denmark, Iceland, Norway, Estonia, Latvia, and Lithuania with additional institutional partners in the European Union. Companies and organizations Electro Motive Diesel and its predecessor Electro Motive Division sold by General Motors, now part of Caterpillar EMD Chemicals, EMD Pharmaceuticals, EMD Serono , and EMD Biosciences in the Merck KGaA group EMD Drive Systems Ltd Electric Motor Development company bought in 2008 by Parvalux Science and technology Earth Mover s Distance , a mathematical measure Einstein Maxwell Dirac equations Electromagnetic Diaphragm , a type of sensor Emerin , a gene associated with Emery Dreifuss muscular dystrophy Hilbert Huang transform Empirical Mode Decomposition , a signal decomposition method Electromechanical dissociation, see Pulseless electrical activity Electro Muscular Disruption weapon, see electroshock weapon Electron Microscopy Databank, see EM Data Bank Oracle Enterprise Manager Oracle Enterprise Manager Database Control Enamel matrix proteins Enamel matrix derivative , otherwise known as enamel matrix proteins, a material intended to regenerate the periodontium supporting tissues of the teeth . Persons E.M.D. refers to Emin Murat Dinlersoz Other E Money Directive EMD Emerging Market Debt , a financial term Earnest money deposit , a type of deposit in real estate dealing European Management Development Centre, see Rino H. C. Schreuder Emergency Medical Dispatcher , a certification obtained to answer, process, and prioritise emergency calls for paramedic response. disambig de EMD fr EMD it EMD ru EMD sv EMD ... more details
by Merck & Co. in 2009. Acquisition of Serono In September 2006 the company announced a takeover bid of 13.2 billion for Serono SA, Switzerland s largest biotech firm. The deal included a buy out of the Ernesto Bertarelli Bertarelli family s 64.5 stake in Serono to be followed by a public tender ... artikel 0,2828,438324,00.html Serono bernahme Mercks Milliardendeal. In manager magazin 21 September ... biotech companies. The new entity, Merck Serono , began operations in 2007. Acquisition of Millipore ... more details
Infobox Company company name Dehns company logo company type Partnership company slogan foundation 1920 location London , Brighton , Oxford , Munich key people num employees 154 industry Law products Legal advice revenue homepage http www.dehns.com www.dehns.com Dehns is the trading name of Frank B. Dehn & Co. , a United Kingdom law firm firm of patent attorney patent and trademark attorney trade mark attorney s, with offices in London , Brighton , Oxford and Munich . It was founded in 1920 by Frank Bernard Dehn. The firm s published client list includes Apple Corps , Serono Ares Serono Group , Boehringer Ingelheim , Borealis , Coca Cola , ConocoPhilips , DuPont , Honda , Kimberly Clark , Medtronic , Otis Elevator Company and Tetley . ref cite web url http www.dehns.com clients client list.asp title Client List accessdate 2010 01 05 publisher Dehns ref The firm Founded in 1920, the practice has offices in London , Brighton , Oxford and Munich . The firm s patent work comes from European direct clients, particularly from Scandinavia, as well as the UK. The firm also acts directly for a large number of US Fortune 500 clients and handles a significant amount of work originating in Japan. Most of its trade mark work comes from the UK and from US direct client companies. Clients include small businesses and private inventors, as well as multinational firms. The firm s straightforward, business oriented approach combined with its technical excellence has made it a leader in its field.Dehns ensures its staff receive training intensive training and has a policy of recruiting highly qualified graduates and post graduates into the firm. The firm has an amazing record of professional examination successes, which has seen the prize for highest marks in the country going to Dehns trainees for three years in a row and four of the past seven. Types of work undertaken The firm advises on all aspects of patenting innovative technology, registering words, logos and other marks and re ... more details
side effects such as hot flushes , headache , nausea and weight gain . ref name SeronoSerono ... with abdominal pain and ovarian hyperstimulation. ref name Serono ref name Organon Subcutaneously ... more details
the new company Merck Serono . He and his sister split a combined 9 billion stake. ref name Forbes After Serono Between 2002 and 2009, he served as a board director of UBS AG. ref http ubs.com 1 e media ... more details
Expand Italian Gaspare Tagliacozzi date June 2009 File Tagliacozzi Portrait.jpg thumb Gasparo Tagliacozzi. Gaspare Tagliacozzi 1546 &ndash 7 November 1599 was an Italy Italian surgery surgeon . Tagliacozzi was born in Bologna . He studied at the University of Bologna under Gerolamo Cardano and others, and, at the age of twenty four, earned his degree in philosophy and medicine . First he was appointed professor of surgery and later was appointed professor of anatomy . He became notorious in his field and is considered the father of Plastic Surgery . He continued the work of the sicilian Surgeon Gustavo Branca and his son Antonio who lived in Catania in the 15th century , developing the so called italian method of plastic surgery which was radically different from the Indian method described in other texts, being much more practical. Tagliacozzi died at Bologna in 1599. Image De curtorum chirurgia 8.jpg 200px right thumb Original illustration of the now called italian method . His principal work is entitled De Curtorum Chirurgia per Insitionem 1597 . Most people now agree that Sushurata , the Ancient India India n doctor who lived in 800 BC is the original father of plastic surgery. Sushruta Samhita , originally in Sanskrit , was translated into Arabic in the 8th century and then traveled further to Italy . ref name Lock607 Lock etc., page 607 ref References Reflist 1911 Jerome Pierce Webster, Martha Teach Gnudi Documenti inediti intorno alla vita di Gaspare Tagliacozzi in Studi e memorie per la storia dell Universit di Bologna , 1935 Pietro Capparoni, Profili bio bibliografici di medici e naturalisti celebri Italiani, dal sec. XV al secolo XVIII , volume 1, Istituto nazionale medico farmacologico Serono , 1926 Alfonso Corradi, Dell antica autoplastica Italiana in Memorie del Regio Istituto lombardo di scienze e lettere. Classe di scienze matematiche e naturali , volume 13, Milano, 1875 Sulla restituzione del naso rapporto del Cavaliere Alberto De Schomberg, Giornal ... more details
Drugbox Monoclonal antibody data Verifiedfields changed verifiedrevid 461092863 type mab mab type mab source zu o target CD11a Clinical data tradename Drugs.com drugs.com monograph efalizumab pregnancy category legal status routes of administration Pharmacokinetic data bioavailability protein bound metabolism elimination half life Identifiers ChemSpiderID Ref chemspidercite correct chemspider ChemSpiderID NA CAS number Ref cascite correct ?? CAS number 214745 43 4 ATC prefix L04 ATC suffix AA21 ATC supplemental PubChem DrugBank Ref drugbankcite changed drugbank DrugBank BTD00074 UNII Ref fdacite correct FDA UNII XX2MN88N5D ChEMBL Ref ebicite changed EBI ChEMBL 1201575 Chemical data chemical formula molecular weight melting point 66 Efalizumab trade name Raptiva , Genentech , Merck Serono is a formerly available medication designed to treat autoimmune diseases, origianally marketed to treat psoriasis . As Nomenclature of monoclonal antibodies implied by the suffix zumab , it is a Recombinant DNA recombinant humanized antibody humanized monoclonal antibody administered once weekly by subcutaneous Injection medicine injection . Efalizumab binds to the CD11a subunit of lymphocyte function associated antigen 1 and acts as an immunosuppressant by inhibiting lymphocyte activation and cell migration out of blood vessels into tissues. Efalizumab was associated with fatal brain infections and was withdrawn from the market in 2009. ref name Major Known side effects include bacterial sepsis , viral meningitis , invasive fungal disease and progressive multifocal leukoencephalopathy PML , a brain infection caused by reactivation of latent JC virus infection. ref name urlEfalizumab FDA Warning cite web url http www.medpagetoday.com InfectiousDisease PublicHealth 11358 title Efalizumab FDA Warning format work accessdate 2008 12 07 ref ref Cite pmid 20073129 ref Four cases of PML were reported in plaque psoriasis patients, an incidence of approximately one in 500 treated patients. r ... more details
Orphan date May 2011 File SamuelWaxman.jpg thumb Samuel Waxman Samuel Waxman is the Zena and Michael A. Wiener Professor of Medicine Cancer , Distinguished Service Professor of Medicine, Hematology, and Medical Oncology, and the Distinguished Service Professor of Oncological Sciences ref http www.mountsinai.org profiles samuel waxman ref at the Mount Sinai School of Medicine in New York City , where he has been a member of the faculty for over 30 years. Dr. Waxman has written hundreds of scientific papers and was one of the first researchers to study differentiation therapy as a method of cancer treatment. He has also authored various chapters in textbooks on subjects including chemotherapy, hematology, and nutrition, and has written the books Differentiation Therapy ref Waxman, Samuel 1995 . Differentiation Therapy. Challenges of Modern Medicine. 10. Ares Serono Symposia. ISBN 8885974317, 9788885974319. ref and The Leukemia Cell . ref Waxman, Samuel and Arnold Rubin 1979 . The Leukemia Cell. CRC immunology and lymphoid cell biology uniscience series. CRC Press. ISBN 0849350093, 9780849350092. ref In 1976, Dr. Waxman founded the Samuel Waxman Cancer Research Foundation, which is now an international organization dedicated to preventing, fighting, and curing cancer. The Waxman Foundation operates a collaborative group called the Institute Without Walls, which is aimed towards bringing researches from around the world together into investigative groups. Since its inception, the Waxman Foundation has provided grants of over 75 million to more than 175 researchers. ref http waxmancancer.org about index.php ref For the 2010 2011 year, the foundation provided grants totaling over 2 million to 13 investigative collaborations and 3 individual researchers. ref http www.waxmancancer.org PR PR 07 13 10.html ref He now serves as the foundation s Scientific Director. Dr. Waxman pursued undergraduate studies at Cornell University , where he received his B.S. in 1957, and attended ... more details
Encyclopedia
top
